Wells Fargo’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-138,508
| Closed | -$7.32M | – | 7396 |
|
|
2020
Q3 | $7.32M | Buy |
138,508
+17,835
| +15% | +$1.1M | ﹤0.01% | 2145 |
|
|
2020
Q2 | $7.39M | Sell |
120,673
-9,354
| -7% | -$541K | ﹤0.01% | 2105 |
|
|
2020
Q1 | $7.36M | Sell |
130,027
-22,471
| -15% | -$1.28M | ﹤0.01% | 1924 |
|
|
2019
Q4 | $8.68M | Buy |
152,498
+26,702
| +21% | +$1.42M | ﹤0.01% | 2072 |
|
|
2019
Q3 | $6.73M | Buy |
125,796
+33,979
| +37% | +$1.98M | ﹤0.01% | 2286 |
|
|
2019
Q2 | $5.48M | Buy |
91,817
+20,830
| +29% | +$1.31M | ﹤0.01% | 2492 |
|
|
2019
Q1 | $4.42M | Buy |
70,987
+20,718
| +41% | +$1.37M | ﹤0.01% | 2676 |
|
|
2018
Q4 | $3.05M | Sell |
50,269
-12,860
| -20% | -$768K | ﹤0.01% | 2917 |
|
|
2018
Q3 | $3.69M | Buy |
63,129
+11,054
| +21% | +$564K | ﹤0.01% | 2911 |
|
|
2018
Q2 | $2.34M | Buy |
52,075
+3,165
| +6% | +$136K | ﹤0.01% | 3342 |
|
|
2018
Q1 | $2.17M | Sell |
48,910
-571
| -1% | -$24K | ﹤0.01% | 3314 |
|
|
2017
Q4 | $2.14M | Buy |
49,481
+4,373
| +10% | +$197K | ﹤0.01% | 3316 |
|
|
2017
Q3 | $2.1M | Sell |
45,108
-6,879
| -13% | -$329K | ﹤0.01% | 3278 |
|
|
2017
Q2 | $2.57M | Sell |
51,987
-20,081
| -28% | -$1.05M | ﹤0.01% | 2996 |
|
|
2017
Q1 | $3.95M | Sell |
72,068
-17,314
| -19% | -$917K | ﹤0.01% | 2630 |
|
|
2016
Q4 | $4.98M | Sell |
89,382
-13,843
| -13% | -$665K | ﹤0.01% | 2409 |
|
|
2016
Q3 | $4.71M | Sell |
103,225
-17,146
| -14% | -$689K | ﹤0.01% | 2318 |
|
|
2016
Q2 | $4.81M | Buy |
120,371
+972
| +0.8% | +$35.6K | ﹤0.01% | 2337 |
|
|
2016
Q1 | $4.16M | Sell |
119,399
-2,244
| -2% | -$82.4K | ﹤0.01% | 2428 |
|
|
2015
Q4 | $5.23M | Buy |
121,643
+31,168
| +34% | +$1.56M | ﹤0.01% | 2290 |
|
|
2015
Q3 | $3.94M | Sell |
90,475
-8,008
| -8% | -$432K | ﹤0.01% | 2493 |
|
|
2015
Q2 | $5.08M | Sell |
98,483
-6,029
| -6% | -$257K | ﹤0.01% | 2403 |
|
|
2015
Q1 | $4.09M | Buy |
104,512
+14,323
| +16% | +$561K | ﹤0.01% | 2526 |
|
|
2014
Q4 | $3.48M | Buy |
90,189
+1,971
| +2% | +$75.2K | ﹤0.01% | 2602 |
|
|
2014
Q3 | $3.11M | Buy |
88,218
+6,849
| +8% | +$201K | ﹤0.01% | 2689 |
|
|
2014
Q2 | $2.19M | Sell |
81,369
-3,909
| -5% | -$102K | ﹤0.01% | 2945 |
|
|
2014
Q1 | $2.21M | Buy |
85,278
+67,884
| +390% | +$1.63M | ﹤0.01% | 2937 |
|
|
2013
Q4 | $377K | Buy |
17,394
+1,378
| +9% | +$28.2K | ﹤0.01% | 3946 |
|
|
2013
Q3 | $312K | Buy |
16,016
+6,261
| +64% | +$111K | ﹤0.01% | 3981 |
|
|
2013
Q2 | $152K | Buy |
+9,755
| New | +$157K | ﹤0.01% | 4258 |
|
Other funds holding BSTC
Wells Fargo's BSTC Position: Q4 2020 in Review
Wells Fargo sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 138,508 shares — an estimated $7.32M sold.
Wells Fargo first reported a position in BSTC in Q2 2013 and held it in 30 quarters. The position peaked at $8.68M in Q4 2019. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- Wells Fargo reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- Wells Fargo sold 138,508 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $7.32M.
- Wells Fargo first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and held it in 30 quarters.
- Wells Fargo's BioSpecifics Technologies Corp. position peaked at $8.68M in Q4 2019.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on Wells Fargo's 13F filing for Q4 2020, filed 9 Feb 2021.